Bert Lynn resumes & CV records
Resumes
Bert Carl Lynn, Age 68108 Caveson Way, Nicholasville, KY 40356
Bert Lynn Phones & Addresses
108 Caveson Way, Nicholasville, KY 40356 (859) 885-8517
Moss Point, MS
1855 Bellefonte Dr, Lexington, KY 40503 (859) 268-5185
2101 Bent Tree Rd, Starkville, MS 39759 (662) 323-8315
105 Bridle Path, Starkville, MS 39759 (662) 323-8315
Miami, FL
Social networks
Bert Carl Lynn
Linkedin
Mentions for Bert Carl Lynn
Publications & IP owners
Wikipedia
Bert Lynn Middle School
Bert Lynn Middle School is a public middle school in Torrance, California. Bert Lynn covers grades 6th through 8th. For over seven years, [when?] the Bert Lynn ...
Us Patents
Biomarkers Of Mild Cognitive Impairment And Alzheimer's Disease
US Patent:
2008002, Jan 31, 2008
Filed:
Jul 25, 2006
Appl. No.:
11/459763
Inventors:
Mark A Lovell - Mt. Vernon KY, US
Bert C. Lynn - Nicholasville KY, US
Bert C. Lynn - Nicholasville KY, US
International Classification:
G01N 33/567
G01N 33/53
G01N 33/53
US Classification:
435 72, 435 792
Abstract:
A method for quantifying a neurodegenerative disorder in a patient that includes obtaining a fluid sample from the subject; measuring a protein biomarker complex in said fluid sample and correlating the measurement with mild cognitive impairment or Alzheimer's disease status. The biomarkers include those that comprise at least one of a transthyretin protein and/or a prostaglandin-H2 D-isomerase protein, and at least one second, different protein selected from a transthyretin, prostaglandin-H2 D-isomerase, beta-2-microglobulin, cystatin C, superoxide dismutase [Cu—Zn], plasma retinol-binding protein, phosphatidylethanolamine-binding protein, carbonic anhydrase 2, prostaglandin-H2 D-isomerase, and/or serotransferrin protein;
Treatment Of Mci And Alzheimer's Disease
US Patent:
2010029, Nov 18, 2010
Filed:
May 13, 2010
Appl. No.:
12/779345
Inventors:
Mark Lovell - Mt. Vernon KY, US
Bert Lynn - Nicholasville KY, US
Bert Lynn - Nicholasville KY, US
Assignee:
The University of Kentucky Research Foundation - Lexington KY
International Classification:
A61K 31/4422
A61K 31/195
A61P 25/28
A61K 31/195
A61P 25/28
US Classification:
514356, 514567
Abstract:
The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent mild cognitive impairment (MCI) or Alzheimer's disease (AD), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, thyroxine (T4), triiodothyronine (T3) and combinations thereof.
Biomarkers Of Mild Cognitive Impairment And Alzheimer's Disease
US Patent:
2011010, May 5, 2011
Filed:
Nov 8, 2010
Appl. No.:
12/941721
Inventors:
Mark A. Lovell - Mt. Vernon KY, US
Bert C. Lynn - Nicholasville KY, US
Bert C. Lynn - Nicholasville KY, US
Assignee:
University of Kentucky Research Foundation - Lexington KY
International Classification:
G01N 33/53
G01N 33/50
C12M 1/34
B01J 19/00
G01N 33/50
C12M 1/34
B01J 19/00
US Classification:
435 792, 436 86, 435 71, 4352872, 422 69
Abstract:
A method for quantifying a neurodegenerative disorder in a patient that includes obtaining a fluid sample from the subject; measuring a protein biomarker complex in said fluid sample and correlating the measurement with mild cognitive impairment or Alzheimer's disease status. The biomarkers include those that comprise at least one of a transthyretin protein and/or a prostaglandin-H2 D-isomerase protein, and at least one second, different protein selected from a transthyretin, prostaglandin-H2 D-isomerase, beta-2-microglobulin, cystatin C, superoxide dismutase [Cu—Zn], plasma retinol-binding protein, phosphatidylethanolamine-binding protein, carbonic anhydrase 2, prostaglandin-H2 D-isomerase, and/or serotransferrin protein;
Treatment Of Mci And Alzheimer's Disease
US Patent:
2011011, May 19, 2011
Filed:
Nov 18, 2010
Appl. No.:
12/949724
Inventors:
Mark Lovell - Mt. Vernon KY, US
Bert Lynn - Nicholasville KY, US
Bert Lynn - Nicholasville KY, US
Assignee:
The University of Kentucky Research Foundation - Lexington KY
International Classification:
A61K 31/4745
C07D 471/04
A61K 31/4418
A61P 25/00
A61P 25/28
C07D 471/04
A61K 31/4418
A61P 25/00
A61P 25/28
US Classification:
514292, 546 81, 514356
Abstract:
The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent a neurological disease (e.g., a neurodegenerative disease, e.g., mild cognitive impairment (MCI) or Alzheimer's disease (AD)), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, lactam (e.g., a compound of formula (Ic) or (Ic-i), e.g., NFD-L1), thyroxine (T4), triiodothyronine (T3) and combinations thereof.
Lobinaline N-Oxides As Positive Allosteric Modulators Of The Dopamine Transporter With Potential Value In The Treatment Of Substance Abuse Disorders
US Patent:
2022040, Dec 22, 2022
Filed:
Nov 25, 2020
Appl. No.:
17/779678
Inventors:
- Lexington KY, US
Bert Lynn - Lexington KY, US
Dennis T. Rogers - Lexington KY, US
Greg Gerhardt - Lexington KY, US
Bert Lynn - Lexington KY, US
Dennis T. Rogers - Lexington KY, US
Greg Gerhardt - Lexington KY, US
International Classification:
A61K 31/4725
A61P 25/32
A61P 25/34
A61P 25/32
A61P 25/34
Abstract:
The presently-disclosed subject matter describes Lobinaline N-oxides as modulators of the dopamine transporter. The presently-disclosed subject matter further describes to Lobinaline N-oxides as modulators of the nicotinic acetylcholine receptors. Also described herein are methods for treating substance abuse disorders comprising administering Lobinaline N-oxides to a subject in need thereof.
On-Farm Integrated High-Solids Processing System For Biomass
US Patent:
2014032, Nov 6, 2014
Filed:
Oct 25, 2013
Appl. No.:
14/063616
Inventors:
- Lexington KY, US
Bert C. Lynn - Nicholasville KY, US
Stephen Rankin - Lexington KY, US
Barbara Knutson - Lexington KY, US
Michael D. Montross - Lexington KY, US
Michael Flythe - Lexington KY, US
Bert C. Lynn - Nicholasville KY, US
Stephen Rankin - Lexington KY, US
Barbara Knutson - Lexington KY, US
Michael D. Montross - Lexington KY, US
Michael Flythe - Lexington KY, US
Assignee:
The University of Kentucky Research Foundation - Lexington KY
International Classification:
C12P 19/02
C12P 7/10
C12P 7/28
C12P 7/16
C12P 7/54
C12P 7/52
C12P 7/10
C12P 7/28
C12P 7/16
C12P 7/54
C12P 7/52
US Classification:
435105, 435140, 435141, 435150, 435160, 435165
Abstract:
A method for on-farm processing a biomass feedstock into a useful industrial chemicals includes the steps of (a) delignifying the biomass feedstock to produce a delignified biomass, (b) subjecting the delignified biomass to cellulase production, (c) subjecting the delignified biomass with attached cellulase to simultaneous cellulolytic and solventogenic reactions to produce useful industrial chemicals (d) collecting and separating the useful industrial chemical from the fermentation broth and (e) collecting the fermentation residues.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.